Valiant Laboratories Limited
Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
What Valiant files
- Others61
- Board Meeting17
- Important12
- Results5
- Updates4
- Credit Ratings3
Valiant Organics will acquire 1.86 Cr shares (34.26% stake) in Valiant Laboratories from promoter Dhanvallabh Ventures LLP. This inter-group transfer, part of a restructuring, will shift ownership within the promoter family. The reference price for this acquisition is ₹62.71 per share.
Valiant Labs' board reviewed fines from exchanges for a delayed Rights Issue meeting notification. They stated the delay was non-deliberate due to practicalities. ₹11,800 fines from each exchange were paid, and the board considers the matter closed.
Valiant Labs has dispatched AGM notices and the FY24-25 Annual Report web-link to shareholders without registered emails. This ensures all investors can access documents for the upcoming 4th Annual General Meeting.
Valiant Laboratories has successfully completed its Rights Issue, allotting 1.09 crore equity shares at ₹75 each. This move raised ₹81.47 crore for the company. Consequently, the paid-up equity share capital has increased from ₹43.45 crore to ₹54.31 crore. The company will now credit shares to allottees' demat accounts. This capital...
Valiant Laboratories Limited has informed the Exchange about Submission of Letter of Offer for Rights Issue of Fully Paid-up Equity Shares.